Michelle Ulrich

1.2k total citations
29 papers, 777 citations indexed

About

Michelle Ulrich is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Michelle Ulrich has authored 29 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Michelle Ulrich's work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and CAR-T cell therapy research (5 papers). Michelle Ulrich is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and CAR-T cell therapy research (5 papers). Michelle Ulrich collaborates with scholars based in United States, Germany and Canada. Michelle Ulrich's co-authors include Turlough O’Donnell, Christopher C. Hanstock, Susan Rotzinger, T. T. NAKASHIMA, Daniel Diolaiti, Robert N. Eisenman, Peter H. Silverstone, Steven Henikoff, Sheila S. Teves and Melissa Conerly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Cell.

In The Last Decade

Michelle Ulrich

28 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Ulrich United States 11 381 247 197 112 90 29 777
Hongjun Jin China 19 465 1.2× 167 0.7× 102 0.5× 49 0.4× 157 1.7× 64 925
Christie E. Delaney Canada 14 472 1.2× 170 0.7× 158 0.8× 20 0.2× 110 1.2× 18 850
T Campbell United Kingdom 14 320 0.8× 179 0.7× 330 1.7× 31 0.3× 88 1.0× 14 987
Pavle Repovic United States 17 222 0.6× 250 1.0× 87 0.4× 37 0.3× 58 0.6× 52 975
Daniela D’Agostino Canada 16 554 1.5× 215 0.9× 80 0.4× 269 2.4× 234 2.6× 27 1.1k
J. Pinski United States 19 341 0.9× 259 1.0× 71 0.4× 35 0.3× 99 1.1× 29 1.1k
Weibo Niu China 19 301 0.8× 281 1.1× 45 0.2× 27 0.2× 180 2.0× 54 866
Monica Baiula Italy 20 432 1.1× 90 0.4× 162 0.8× 21 0.2× 45 0.5× 56 896
Garth Cruickshank United Kingdom 15 345 0.9× 179 0.7× 166 0.8× 10 0.1× 239 2.7× 23 899
Francesca Casagrande Italy 19 326 0.9× 224 0.9× 78 0.4× 11 0.1× 51 0.6× 29 905

Countries citing papers authored by Michelle Ulrich

Since Specialization
Citations

This map shows the geographic impact of Michelle Ulrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Ulrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Ulrich more than expected).

Fields of papers citing papers by Michelle Ulrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Ulrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Ulrich. The network helps show where Michelle Ulrich may publish in the future.

Co-authorship network of co-authors of Michelle Ulrich

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Ulrich. A scholar is included among the top collaborators of Michelle Ulrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Ulrich. Michelle Ulrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hensley, Kelly, et al.. (2023). HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast Cancer. Cancer Research Communications. 3(9). 1927–1939. 6 indexed citations
2.
Gosink, John J., Michelle Ulrich, Liya Huang, et al.. (2023). Abstract 1522: SGN-B6A induces immunogenic cell death as an additional mechanism of action. Cancer Research. 83(7_Supplement). 1522–1522. 2 indexed citations
3.
Heiser, Ryan A., Anthony Cao, Weiping Zeng, et al.. (2023). Brentuximab Vedotin–Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity. Molecular Cancer Therapeutics. 23(1). 68–83. 28 indexed citations
4.
Heiser, Ryan A., Michelle Ulrich, Jason D. Berndt, et al.. (2023). Abstract 3253: CD30 is a marker of activated effector regulatory T cells in solid tumors providing clinical rationale for the combination of brentuximab vedotin and PD-1 inhibitors. Cancer Research. 83(7_Supplement). 3253–3253. 3 indexed citations
5.
Ulrich, Michelle, et al.. (2023). Sex differences in anxiety and threat avoidance in GAD65 knock-out mice. Neurobiology of Disease. 183. 106165–106165. 2 indexed citations
6.
Klussman, Kerry, Jessica K. Simmons, Michelle Ulrich, et al.. (2023). Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs. Cancer Research. 83(7_Supplement). 2013–2013. 2 indexed citations
7.
Gruber, David, Michelle Ulrich, Kaleb Smith, et al.. (2023). 1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models. SHILAP Revista de lepidopterología. A1227–A1227. 1 indexed citations
8.
Gray, Elizabeth, Angela Epp, Michelle Ulrich, et al.. (2021). 854 SGN-B7H4V, a novel, investigational vedotin antibody-drug conjugate directed to the T cell checkpoint ligand B7-H4, shows promising activity in preclinical models. SHILAP Revista de lepidopterología. A895–A895. 3 indexed citations
9.
Kulukian, Anita, Albina Nesterova, Kelly Hensley, et al.. (2020). Abstract 1962: Preclinical characterization of tucatinib in HER2-amplified xenograft and CNS implanted tumors. Cancer Research. 80(16_Supplement). 1962–1962. 2 indexed citations
10.
Li, Fu, Michelle Ulrich, Vincent Feng-Sheng Shih, et al.. (2019). Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody–Drug Conjugate Via Fc–FcγR Interaction. Molecular Cancer Therapeutics. 18(4). 780–787. 37 indexed citations
11.
Neumann, Christopher S., Martha E. Anderson, Julia H. Cochran, et al.. (2018). Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 17(12). 2633–2642. 32 indexed citations
12.
Li, Fu, Michelle Ulrich, Mechthild Jonas, et al.. (2017). Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(7). 1347–1354. 53 indexed citations
13.
Burke, Patrick, Scott C. Jeffrey, Joshua H. Hunter, et al.. (2016). Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 16(1). 116–123. 110 indexed citations
14.
Fu, Li, Michelle Ulrich, Mechthild Jonas, et al.. (2016). Abstract 1285: Tumor associated macrophages can process antibody-drug conjugates and contribute to antitumor activity in preclinical xenograft models. Cancer Research. 76(14_Supplement). 1285–1285. 2 indexed citations
15.
Carroll, Patrick A., Daniel Diolaiti, Lisa McFerrin, et al.. (2015). Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis. Cancer Cell. 27(2). 271–285. 158 indexed citations
16.
Hatton, Beryl A., Elisabeth H. Villavicencio, Joel I. Pritchard, et al.. (2010). Notch signaling is not essential in sonic hedgehog-activated medulloblastoma. Oncogene. 29(26). 3865–3872. 16 indexed citations
17.
Conerly, Melissa, Sheila S. Teves, Daniel Diolaiti, et al.. (2010). Changes in H2A.Z occupancy and DNA methylation during B-cell lymphomagenesis. Genome Research. 20(10). 1383–1390. 103 indexed citations
18.
O’Donnell, Turlough, Susan Rotzinger, T. T. NAKASHIMA, et al.. (2000). Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Research. 880(1-2). 84–91. 132 indexed citations
19.
Adler, L., Michelle Ulrich, Kenneth G. Lehmann, et al.. (1994). Praxis der stationären Akutbehandlung von Manien. Fortschritte der Neurologie · Psychiatrie. 62(12). 479–488. 4 indexed citations
20.
Barrowman, J. A., et al.. (1981). Effects of bradykinin on intestinal transcapillary fluid exchange. Canadian Journal of Physiology and Pharmacology. 59(8). 786–789. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongjun Jin Breakdown of academic impact, for papers by Christie E. Delaney Breakdown of academic impact, for papers by T Campbell Breakdown of academic impact, for papers by Pavle Repovic Breakdown of academic impact, for papers by Daniela D’Agostino Breakdown of academic impact, for papers by J. Pinski Breakdown of academic impact, for papers by Weibo Niu Breakdown of academic impact, for papers by Monica Baiula Breakdown of academic impact, for papers by Garth Cruickshank Breakdown of academic impact, for papers by Francesca Casagrande
Rankless by CCL
2026